Ireland· IE-PA-PA2315/269/001
Tacrolimus 0.03% ointment
A tacrolimus product containing tacrolimus, registered in Ireland by Accord Healthcare Ireland Ltd.. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tacrolimus is registered in 12 of 19 countries.
Countries holding a registration under ATC D11AH01 (tacrolimus), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Tacrolimus · ATC D11AH01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Tacrolimus
- Manufacturer
- Accord Healthcare Ireland Ltd.
- Country
- Ireland (IE)
- ATC code
- D11AH01
- ATC class
- Tacrolimus
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2315/269/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tacrolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADVAGRAFAstellas Pharma Europe B.V., Leiden
- United StatesASTAGRAF XLAstellas Pharma US, Inc.
- SwedenAdoport 0,5 mg Kapsel, hårdEbb Medical AB
- United KingdomAdoport 0.5mg capsulesSandoz Ltd
- NetherlandsAdport 0,5 mg, capsules, hardEuro Registratie Collectief B.V.
- FinlandAdportSandoz A/S
- SpainADOPORT 0,5 mg CAPSULAS DURAS EFGSandoz Farmaceutica S.A.
- SwitzerlandAdvagraf
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Adport, Dailiport
- Belgium · Adoport, Dailiport
- Bulgaria · Програф
- Cyprus · Prograf, Tacrolimus Accord
- Czechia · Dailiport, Gecrol
- Germany · Crilomus, Dailiport
- Denmark · Adport, Dailiport
- Estonia · Dailiport, Lebsanan
- Spain · Adoport, Cellmune
- Finland · Adport, Adport,
- France · Adoport, Conferoport
- United Kingdom (Northern Ireland) · Adoport, Ascezo
- Greece · Atodrit-Dermo, Eczatope Derm
- Croatia · Atezyrix, Dermitopic
- Hungary · Prograf, Tacrolimus Stada
- Iceland · Advagraf, Dailiport
- Italy · Adoport, Carelimus
- Liechtenstein · Advagraf, Envarsus
- Lithuania · Dailiport, Lebsanan
- Luxembourg · Prograft, Sumilor
- Latvia · Dailiport, Lebsanan
- Malta · Prograf
- Netherlands · Adport, Conferoport
- Norway · Adport, Advagraf
- Poland · Cidimus, Dailiport
- Portugal · Adoport, Dermitopic
- Romania · Prograf, Tacrolimus Sandoz
- Sweden · Adport, Adport,
- Slovenia · Adoport, Dailiport
- Slovakia · Atezyrix, Dailiport
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd801d6f-7dc1-419d-b23a-6845ec7e0ce6 GET /v1/drugs/bd801d6f-7dc1-419d-b23a-6845ec7e0ce6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Ointment",
"routes": [
"Cutaneous use"
],
"source": "hpra",
"atc_all": [
"D11AH01"
],
"strength": null,
"pa_number": "PA2315/269/001",
"substances": [
"Tacrolimus"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "11/11/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tacrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.